Project Grant R01DK148601
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Research Foundation For The State University Of New York $2,745,108 on September 11, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847, Project Grant R01DK143260). The recipient will develop microfluidic devices that replicate the dimensions and branched structures of human kidney vasculature to investigate systemic amyloidosis. The devices will subject...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Research Foundation for the State University of New York $327,450 on August 20, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct research on reducing geographic disparity in access to deceased donor kidney transplantation. The recipient will employ advanced statistical methods, artificial intelligence, and operations research to understand complex dynamics...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Research Foundation For The State University Of New York $798,814 on August 1, 2026, for a randomized controlled trial testing continuous glucose monitoring combined with health coaching and values clarification in older adults with poorly controlled type 2 diabetes. The intervention targets 300 participants aged 65 and older with hemoglobin A1c of 9 percent or higher, randomized 1:1 to the intervention or...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded $1,527,305 to The Research Foundation For The State University Of New York (operating as Stony Brook University) on August 21, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct research on C-terminal binding protein 2 (CTBP2) as a therapeutic target in acute kidney injury. The research identifies CTBP2, a redox-sensitive, NAD/NADH-dependent transcriptional...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Research Foundation For The State University Of New York (operating as Stony Brook University) $738,152 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on July 1, 2026, for basic research investigating IL-17A-mediated regulation of stromal and epithelial cell interactions in the intestine. The research addresses a critical gap in understanding how IL-17A signaling in...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded New York University School of Medicine $2,557,884 on September 10, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct a detailed analysis of long-term health outcomes in living kidney donors using real-world electronic health records. The recipient will analyze the COSMOS dataset, which encompasses electronic health records from over 245 million individuals...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a Project Grant totaling $155,562 to Stony Brook University (operating through The Research Foundation For The State University Of New York) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, dated December 11, 2025, supports research investigating alterations of branched chain amino acid (BCAA) catabolism in acute kidney injury...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded New York University $872,273 on August 20, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to identify modifiable process delays in deceased donor kidney allocation through process mining analysis. The project applies process mining methodology to discover actual kidney placement workflows from data logs at multiple organ procurement organizations (OPOs). The research...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Illinois $160,575 on July 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847, Project Grant K01DK147658). The award funds a three-year study of Medicaid alternative payment model (APM) implementation and evidence-based practice adoption in federally qualified health centers (FQHCs) to improve diabetes outcomes. The research addresses how FQHCs, which...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Arkansas for Medical Sciences $717,457 on February 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate metabolic rewiring of T cells and the pathogenic connection between diabetes and hypertension. The research examines immune-metabolic crosstalk in the progression from type 2 diabetes to hypertension using a high-fat diet-induced...
The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Research Foundation For The State University Of New York $800,434 on August 24, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct a conditional cash transfer and basic needs resolution intervention for low-income adults with Type 2 Diabetes. The award funds research addressing the disproportionate burden of Type 2 Diabetes among individuals living below 133 percent of the federal poverty level or eligible for Medicaid, populations that experience significantly higher prevalence, morbidity, mortality, and health care costs compared to higher-income individuals. The project examines whether conditional cash transfers tied to achievement of the ABCs of diabetes care—glycated hemoglobin below 7 percent, blood pressure control, and other clinical markers known to predict morbidity and mortality outcomes—can improve adherence and metabolic control in this vulnerable population. RF SUNY, doing business as Sponsored Projects Services, serves as fiscal agent and sponsored programs administrator for the State University of New York system. Performance occurs in Buffalo, New York. The period of performance runs from August 24, 2026, through June 30, 2031.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $800.4k | 8/24/26 |